Live varicella virus vaccine (Merck Sharp & Dohme)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLive varicella virus vaccine (Merck Sharp & Dohme)
Drug Alias Name活水痘病毒疫苗-默沙东Provarivax
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Corp
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsHerpes Zoster

Other Information

ATC CodeJ07BK01
Related LinksN/A